Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP606161.RAfgfkb9bhyC4z7yvOc2_npiTqwX4OPbbXiUF5nPsxNuQ130_assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606161.RAfgfkb9bhyC4z7yvOc2_npiTqwX4OPbbXiUF5nPsxNuQ130_provenance.
• NP873323.RAd-BsxV4ZXxbL-U74E14lP3BdAgGauDrYfdvSpGhj6bw130_assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873323.RAd-BsxV4ZXxbL-U74E14lP3BdAgGauDrYfdvSpGhj6bw130_provenance.
• assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP781591.RAsD3N0TkKRutD7P0WvDLWsMr4cPFqaaOqCWnRpEe3J5s130_assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781591.RAsD3N0TkKRutD7P0WvDLWsMr4cPFqaaOqCWnRpEe3J5s130_provenance.
• NP394612.RAeCtu1ds32UetcBtaBdfqbTKvkPyx23MWtBlfNTtHZh0130_assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394612.RAeCtu1ds32UetcBtaBdfqbTKvkPyx23MWtBlfNTtHZh0130_provenance.
• NP394617.RAU_AaBUR8kbXdykBBrVedBzvtqikMd91RC_pSsOnTmXE130_assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394617.RAU_AaBUR8kbXdykBBrVedBzvtqikMd91RC_pSsOnTmXE130_provenance.
• assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP914210.RAk4bvdaZAxvTZ3bVEXVwN_vqoMipBAms-bE6p4OTBH6w130_assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914210.RAk4bvdaZAxvTZ3bVEXVwN_vqoMipBAms-bE6p4OTBH6w130_provenance.
• NP978681.RA1zcgG7wF95BYoqFEdBQs7kG-yZEEpUAKdGdeuWxPuC8130_assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978681.RA1zcgG7wF95BYoqFEdBQs7kG-yZEEpUAKdGdeuWxPuC8130_provenance.
• NP394613.RA3X3sLjVCkHAuE59uS85eHOo7cgKAyYfjQW5VDLJFiLE130_assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394613.RA3X3sLjVCkHAuE59uS85eHOo7cgKAyYfjQW5VDLJFiLE130_provenance.
• NP394615.RAy567KAey0b8dKPwQh2M71lpUijbeIvVet0pE4upsxaU130_assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394615.RAy567KAey0b8dKPwQh2M71lpUijbeIvVet0pE4upsxaU130_provenance.
• NP394620.RA3Whwp3Dd-dgx_JxWWoS6t1PN36P6AA4x6tFQckQFETI130_assertion description "[Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394620.RA3Whwp3Dd-dgx_JxWWoS6t1PN36P6AA4x6tFQckQFETI130_provenance.